Formulation development and preliminary biological evaluation of a menthol modified thermoresponsive tamoxifen sol-gel
Medical Oncology · 2026
DOI: 10.1007/s12032-026-03335-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, 2026. Verfasst von Saleha Faheem und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, University of Central Punjab, Lahore, 54000, Pakistan. Hauptthemen laut MEDLINE: Tamoxifen, Menthol, Antineoplastic Agents, Hormonal, Breast Neoplasms. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University.
Abstract (Originalsprache)
Localized drug delivery strategies offer potential advantages in improving therapeutic concentration at tumor sites while minimizing systemic exposure. In this study, a thermoresponsive poloxamer based sol-gel system incorporating tamoxifen citrate with L-menthol was developed and characterized for potential intratumoral application. The formulation was prepared using the cold method and optimized through response surface methodology\. The optimized system exhibited rapid sol-gel transition at 38.5 °C with gelation time around 37s, acceptable syringeability, pH compatibility with mildly acidic tumor conditions, and uniform drug content (93-96%) with high encapsulation efficiency (88-93%). In vitro release studies demonstrated sustained tamoxifen release over 48 h, best described by the Korsmeyer-Peppas model (n = 0.366), indicating diffusion-controlled release. Physicochemical analyses (FTIR, DSC, XRD, SEM) confirmed drug excipient compatibility and partial amorphization within the polymeric matrix. Molecular docking provided preliminary insight into potential interactions with breast cancer associated proteins. In vitro cytotoxicity in MCF-7 cells showed reduced IC₅₀ values for the menthol containing formulation compared to tamoxifen alone. Acute toxicity evaluation in mice indicated acceptable short-term tolerability. Overall, this system represents a promising localized delivery platform warranting further mechanistic and in vivo efficacy investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, University of Central Punjab, Lahore, 54000, Pakistan.
- Faculty of Pharmaceutical Sciences, University of Central Punjab, Lahore, 54000, Pakistan. huma.hameed@ucp.edu.pk.
- Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11623, Riyadh, Saudi Arabia.
- The Green Institute of Chemical Biomedical and Environmental Sciences (GICBES), Lahore, 54000, Pakistan.
- College of Pharmacy, University of Sargodha, Sargodha, 40100, Pakistan.
- Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11623, Riyadh, Saudi Arabia. mezaki@imamu.edu.sa.
ORCID-Profile: Magdi E A Zaki
Förderung
- Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University
Zitieren
APA
Faheem, S., Hameed, H., Al-Hussain, S. A., Irfan, A., Ghumman, S. A., & Zaki, M. E. A. (2026). Formulation development and preliminary biological evaluation of a menthol modified thermoresponsive tamoxifen sol-gel. Medical Oncology. https://doi.org/10.1007/s12032-026-03335-1
Vancouver
Faheem S, Hameed H, Al-Hussain SA, Irfan A, Ghumman SA, Zaki MEA. Formulation development and preliminary biological evaluation of a menthol modified thermoresponsive tamoxifen sol-gel. Medical Oncology. 2026. doi:10.1007/s12032-026-03335-1
BibTeX
@article{Faheem2026,
author = {Faheem, Saleha and Hameed, Huma and Al-Hussain, Sami A and Irfan, Ali and Ghumman, Shazia Akram and Zaki, Magdi E A},
title = {Formulation development and preliminary biological evaluation of a menthol modified thermoresponsive tamoxifen sol-gel},
journal = {Medical Oncology},
year = {2026},
doi = {10.1007/s12032-026-03335-1}
}
EUVIMED